| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $105K | — | +121.8% |
| Cost of Revenue | $57K | — | +385.5% |
| R&D Expense | $2.9M | — | +37.1% |
| SG&A Expense | $4.1M | — | +30.4% |
| Operating Income | -$6.9M | — | -33.1% |
| Net Income | -$6.5M | — | +14.6% |
| EPS (Basic) | -$0.59 | — | +91.1% |
| EPS (Diluted) | -$0.59 | — | +91.1% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $5.1M | +418.3% | +412.0% |
| Short-term Investments | $39.2M | +16.3% | +155.9% |
| Accounts Receivable | $2.7M | +76.9% | — |
| Inventory | $1.8M | -12.5% | +97.8% |
| Current Assets | $49.9M | +25.4% | +166.6% |
| Total Assets | $61.0M | +21.8% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$8.4M | — | -29.0% |
| Capital Expenditures | $289K | — | +62.2% |
| Investing Cash Flow | -$5.4M | — | +66.6% |
| Financing Cash Flow | $17.9M | — | — |
| Free Cash Flow | -$8.7M | — | -29.9% |
| +150.4% |
| Current Liabilities | $4.1M | -13.9% | +87.4% |
| Total Liabilities | $10.4M | -8.1% | +370.9% |
| Stockholders' Equity | $50.6M | +30.5% | +128.4% |